Journal Section:
Commentary
References
1.
Makram
OM
, Okwuosa
T
, Addison
D
, Cortes
J
, Dent
S
, Bevel
M
, et al. Cardiovascular diseases increase cancer mortality in adults: NHANES-continuous study
. J Am Heart Assoc
. 2024
;13
(15
):e035500
. 2.
Agarwal
MA
, Aggarwal
A
, Rastogi
S
, Ventura
HO
, Lavie
CJ
. Cardiovascular disease burden in cancer patients from 2003 to 2014
. Eur Heart J Qual Care Clin Outcomes
. 2018
;4
(1
):69
–70
. 3.
Wilcox
NS
, Amit
U
, Reibel
JB
, Berlin
E
, Howell
K
, Ky
B
. Cardiovascular disease and cancer: shared risk factors and mechanisms
. Nat Rev Cardiol
. 2024
;21
(9
):617
–31
. 4.
Rawla
P
. Epidemiology of prostate cancer
. World J Oncol
. 2019
;10
(2
):63
–89
. 5.
Leong
DP
, Guha
A
, Morgans
AK
, Niazi
T
, Pinthus
JH
. Cardiovascular risk in prostate cancer: JACC – CardioOncology state-of-the-art review
. JACC CardioOncol
. 2024
;6
(6
):835
–46
. 6.
Faris
JE
, Smith
MR
. Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
. Curr Opin Endocrinol Diabetes Obes
. 2010
;17
(3
):240
–6
. 7.
Stødkilde-Jørgensen
N
. Prognostic impact of coronary calcifications in patients with recently diagnosed prostate cancer
. Cardiology
. 2025
. Accepted, not yet published.8.
Curigliano
G
, Lenihan
D
, Fradley
M
, Ganatra
S
, Barac
A
, Blaes
A
, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
. Ann Oncol
. 2020
;31
(2
):171
–90
. 9.
Pollock
PA
, Ludgate
A
, Wassersug
RJ
. In 2124, half of all men can count on developing prostate cancer
. Curr Oncol
. 2015
;22
(1
):10
–2
. 10.
Lin
CA
, Kao
YS
. Prostate cancer and cardiovascular risk factors
. JACC CardioOncol
. 2023
;5
(4
):551
. 11.
Aengevaeren
VL
, Mosterd
A
, Sharma
S
, Prakken
NHJ
, Möhlenkamp
S
, Thompson
PD
, et al. Exercise and coronary atherosclerosis: observations, explanations, relevance, and clinical management
. Circulation
. 2020
;141
(16
):1338
–50
. 12.
Mayntz
SK
, Peronard
CRF
, Søgaard
J
, Chang
AY
. The economic burden of diseases in the Nordic countries: a systematic review
. Scand J Public Health
. 2024
;52
(2
):234
–46
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended...
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.